BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 8172890)

  • 1. Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2.
    Blanke SR; Huang K; Wilson BA; Papini E; Covacci A; Collier RJ
    Biochemistry; 1994 May; 33(17):5155-61. PubMed ID: 8172890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active-site mutations of diphtheria toxin: role of tyrosine-65 in NAD binding and ADP-ribosylation.
    Blanke SR; Huang K; Collier RJ
    Biochemistry; 1994 Dec; 33(51):15494-500. PubMed ID: 7803411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
    Bell CE; Eisenberg D
    Biochemistry; 1996 Jan; 35(4):1137-49. PubMed ID: 8573568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active-site mutations of diphtheria toxin: effects of replacing glutamic acid-148 with aspartic acid, glutamine, or serine.
    Wilson BA; Reich KA; Weinstein BR; Collier RJ
    Biochemistry; 1990 Sep; 29(37):8643-51. PubMed ID: 1980208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL; Iglewski WJ; Moehring JM; Moehring TJ
    Eur J Biochem; 1992 Apr; 205(1):25-31. PubMed ID: 1313365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphtheria toxin NAD affinity and ADP ribosyltransferase activity are reduced at tryptophan 153 substitutions for alanine or phenylalanine.
    Zdanovskaia MV; Zdanovsky AG; Yankovsky NK
    Res Microbiol; 2000 Sep; 151(7):557-62. PubMed ID: 11037133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin.
    Xu Y; Barbançon-Finck V; Barbieri JT
    J Biol Chem; 1994 Apr; 269(13):9993-9. PubMed ID: 8144593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
    Giovane A; Balestrieri C; Quagliuolo L; Servillo L
    FEBS Lett; 1985 Oct; 191(2):191-4. PubMed ID: 2996930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2.
    Oppenheimer NJ; Bodley JW
    J Biol Chem; 1981 Aug; 256(16):8579-81. PubMed ID: 6267047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active-site mutations of diphtheria toxin. Tryptophan 50 is a major determinant of NAD affinity.
    Wilson BA; Blanke SR; Reich KA; Collier RJ
    J Biol Chem; 1994 Sep; 269(37):23296-301. PubMed ID: 8083236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of non-ADP-ribosylatable, diphtheria toxin-resistant elongation factor 2 in Saccharomyces cerevisiae.
    Kimata Y; Harashima S; Kohno K
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1145-51. PubMed ID: 8466491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NAD-glycohydrolase activity of the pertussis toxin S1 subunit. Involvement of the catalytic HIS-35 residue.
    Antoine R; Locht C
    J Biol Chem; 1994 Mar; 269(9):6450-7. PubMed ID: 8119996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O; Nilsson L
    Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6902-6. PubMed ID: 8692916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of 2'-deoxynad for ADP-ribose transfer reactions.
    Wasson DB; Yamanaka H; Carson DA
    Adv Exp Med Biol; 1989; 253B():213-8. PubMed ID: 2514587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M; Nurten R; Ergen K; Bermek E
    Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
    Beattie BK; Prentice GA; Merrill AR
    Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
    Wilson BA; Collier RJ
    Curr Top Microbiol Immunol; 1992; 175():27-41. PubMed ID: 1628498
    [No Abstract]   [Full Text] [Related]  

  • 20. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide.
    Bell CE; Eisenberg D
    Adv Exp Med Biol; 1997; 419():35-43. PubMed ID: 9193634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.